Price $1.26 |
Market Cap
198.3M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
1.6
|
P/B
0.52
|
P/S
0.78
|
Dividend %
-
|
|
P/CF
7.4
|
P/FCF
1.8
|
Op. Cash Flow
78.1K
|
FCF
1.2
|
|
Op. Margin
14.50%
|
Net Margin
58.20%
|
ROE
45.20%
|
ROI
40.30%
|
|
ROA
25.10%
|
EPS Growth
260.60%
|
Current Ratio
1.4
|
Debt/Equity
29.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| ZimVie Inc (ZIMV) | $16.93 | - | - | 197.4M | Strong Buy |
| Nabriva Therapeutics PLC - ADR (NBRVF) | $0.00 | - | - | 1.7M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.00 | - | - | 5M | Strong Buy |
| Myomo Inc (MYO) | $3.77 | - | - | 35.8M | Strong Buy |
| Marizyme Inc (MRZM) | $0.03 | - | - | 8.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
